ArticleFrontiers in medicine2025
Non-linear association of the alanine aminotransferase to high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease: a secondary analysis of a Chinese cohort.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a major public health concern, with rising prevalence worldwide. The alanine aminotransferase to high-density lipoprotein cholesterol (ALT/HDL-C) ratio has emerged as a potential marker of metabolic dysfunction, but its association with NAFLD remains underexplored, particularly in Chinese populations. This study aimed to investigate the independent and nonlinear association between the ALT/HDL-C ratio and NAFLD in Chinese adults. Methods: This was a secondary analysis of a cross-sectional dataset. A total of 1,592 Chinese adults aged 40-70 years who underwent health checkups were included. NAFLD was diagnosed via abdominal ultrasound. The ALT/HDL-C ratio was calculated and analyzed as both a continuous and categorical variable (tertiles). Multivariable logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic curves were used to assess the association and predictive performance of the ALT/HDL-C ratio for NAFLD. Results: The prevalence of NAFLD was 61.1%. After full adjustment, each one standard deviation increase in the ALT/HDL-C ratio was associated with a 79% higher odds of NAFLD (odds ratio [OR] = 1.79, 95% CI: 1.39-2.31, Conclusion: The ALT/HDL-C ratio is independently and nonlinearly associated with NAFLD in Chinese adults, with a particularly strong association in non-elderly individuals and women. This simple and readily available biomarker shows promise for enhancing NAFLD risk stratification in middle-aged adults, while its utility in the elderly population may be limited and requires further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.